MUSCLE INVASIVE BLADDER CANCER

Clinical trials for MUSCLE INVASIVE BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new MUSCLE INVASIVE BLADDER CANCER trials appear

Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 3 Not yet finished but already full! 5 Completed 1 Terminated 1

Terminated trial: can radiation plus immune drug fight bladder cancer?

Disease control Terminated

This study tested whether adding an immunotherapy drug called avelumab to standard bladder radiation could help treat muscle-invasive bladder cancer. It was specifically for patients who were unable to receive the usual chemotherapy. The trial was terminated early after enrolling…

Matched conditions: MUSCLE INVASIVE BLADDER CANCER

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

MUSCLE INVASIVE BLADDER CANCER

Get alerted when new MUSCLE INVASIVE BLADDER CANCER trials appear

Terminated trial: can radiation plus immune drug fight bladder cancer?